⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL355242 | 1.00 | — | — | |
| SCHEMBL271371 | 1.00 | — | — | |
| Fluoride SCHEMBL31281119 | 0.95 | — | — | |
| Water SCHEMBL31281739 | 0.95 | — | — | |
| Hydrochloric Acid SCHEMBL1978156 | 0.95 | — | — | |
| Hydrochloric Acid SCHEMBL25273278 | 0.95 | — | — | |
| Hydrochloric Acid SCHEMBL5206284 | 0.95 | — | — | |
| SCHEMBL7671989 | 0.76 | ALDH1A1 (0.31) | — | |
| SCHEMBL21100089 | 0.76 | — | — | |
| SCHEMBL239610 | 0.76 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 597 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250387385-A1 | TREATMENT FOR GLOMERULAR DISEASES | ZYDUS LIFESCIENCES LIMITED (IN) | 2025-12-25 | — | — | US | claimed |
| EP-4565233-A1 | TREATMENT FOR APLASTIC ANEMIA (AA) | Zydus Lifesciences Limited (IN) | 2025-06-11 | — | — | EP | claimed |
| EP-4539934-A1 | TREATMENT FOR GLOMERULAR DISEASES | Zydus Lifesciences Limited (IN) | 2025-04-23 | — | — | EP | claimed |
| CN-119816306-A | Treatment of Aplastic Anemia (AA) | 载度思生命科学有限公司 | 2025-04-11 | — | — | CN | claimed |
| CN-119486735-A | For the treatment of glomerular diseases | 载度思生命科学有限公司 | 2025-02-18 | — | — | CN | claimed |
| CN-115960325-B | Ultrathin chiral fluorescent covalent organic framework nano-sheet and preparation method and application thereof | 中国科学院福建物质结构研究所 | 2024-11-12 | — | — | CN | claimed |
| US-12104106-B2 | Compositions of chiral molecules and perovskite nanocrystals and methods of making the same | ALLIANCE FOR SUSTAINABLE ENERGY, LLC (US) | 2024-10-01 | — | — | US | claimed |
| US-20240173314-A1 | TREATMENT OF SICKLE CELL ANAEMIA | ZYDUS LIFESCIENCES LTD. (IN) | 2024-05-30 | — | — | US | claimed |
| WO-2024028744-A1 | TREATMENT FOR APLASTIC ANEMIA (AA) | ZYDUS LIFESCIENCES LIMITED (IN) | 2024-02-08 | — | — | WO | claimed |
| EP-4308120-A1 | TREATMENT FOR SICKLE CELL ANAEMIA | Zydus Lifesciences Limited (IN) | 2024-01-24 | — | — | EP | claimed |
| US-20090069581-A1 | PROCESS FOR THE SYNTHESIS OF RAMELTEON AND ITS INTERMEDIATES | TEVA PHARMACEUTICAL INDUSTRIES LTD. (IL) | 2009-03-12 | — | — | US | claimed |
| WO-2008151170-A2 | PROCESS FOR THE SYNTHESIS OF RAMELTEON AND ITS INTERMEDIATES | TEVA PHARMACEUTICAL INDUSTRIES LTD. (IL) | 2008-12-11 | — | — | WO | claimed |
| US-7166628-B2 | Cytokine inhibitors | BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) | 2007-01-23 | — | — | US | claimed |
| EP-1567507-B1 | 1,2,3- TRIAZOLE AMIDE DERIVATIVES AS CYTOKINE INHIBITORS | BOEHRINGER INGELHEIM PHARMA (US) | 2006-06-14 | — | — | EP | claimed |
| EP-0857790-B1 | PROCESS FOR PRODUCING OPTICALLY ACTIVE AMINO COMPOUNDS | KANEKA CORP (JP) | 2005-08-17 | — | — | EP | claimed |
| US-20040102492-A1 | Cytokine inhibitors | BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. | 2004-05-27 | — | — | US | claimed |
| US-20010031487-A1 | Process for producing optically active amino compounds | KANEKA CORPORATION | 2001-10-18 | — | — | US | claimed |
| US-6221638-B1 | BY STEREOSELECTIVELY CARRYING OUT AMINO GROUP TRANSFER BY ACTION OF AN (R)-FORM-SPECIFIC TRANSAMINASE IN THE CO-PRESENCE OF A KETONE (AMINO ACCEPTOR) AND AMINO COMPOUND (AMINO DONOR); YIELDS AMINO COMPOUNDS HAIVNG ARYL GROUP AT THE 1-POSITION | KANEKA CORPORATION (JP) | 2001-04-24 | — | — | US | claimed |
| EP-0987332-A1 | PROCESS FOR PRODUCING OPTICALLY ACTIVE AMINO COMPOUNDS | Kaneka Corporation (JP) | 2000-03-22 | — | — | EP | claimed |
| EP-0857790-A1 | PROCESS FOR PRODUCING OPTICALLY ACTIVE AMINO COMPOUNDS | KANEKA CORPORATION (JP) | 1998-08-12 | — | — | EP | claimed |